Skip to main
SBRA

SBRA Stock Forecast & Price Target

SBRA Analyst Ratings

Based on 8 analyst ratings
Hold
Strong Buy 0%
Buy 38%
Hold 63%
Sell 0%
Strong Sell 0%

Bulls say

Sabra Health Care REIT Inc. presents a positive outlook due to improving occupancy rates and rent coverage, which enhances its financial stability and overall valuation. The anticipated recovery in the seniors housing managed portfolio is expected to strengthen the company's leverage profile, enabling Sabra to pursue growth opportunities more effectively. Additionally, favorable demand drivers in healthcare real estate, alongside Sabra's above-average RIDEA exposure, position the company advantageously within its sector.

Bears say

The financial analysis indicates that Sabra Health Care REIT faces challenges related to operator performance, particularly in an inflationary environment, where certain operators are struggling to meet rent obligations. Additionally, the company’s leverage is higher compared to several peers, which could pose risks in an increasingly competitive healthcare REIT sector. Furthermore, trading near the high end of its 10-year valuation range, the current cost of equity suggests limited potential for earnings accretion from new acquisitions, contributing to a negative outlook for the stock.

SBRA has been analyzed by 8 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 38% recommend Buy, 63% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Sabra Health Care and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Sabra Health Care (SBRA) Forecast

Analysts have given SBRA a Hold based on their latest research and market trends.

According to 8 analysts, SBRA has a Hold consensus rating as of Dec 25, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $20.62, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $20.62, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Sabra Health Care (SBRA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.